It's time to complete your JBC Methods Madness bracket
Calling all scientists! Do you have a favorite method? Is there a biochemical technique you think has had monumental impacts on basic research and deserves a moment in the spotlight? The Journal of Biological Chemistry’s Methods Madness tournament is the chance you’ve been waiting for to voice your opinions. The person with the top-scoring bracket will win a $50 gift card.
How to participate
- Download and fill in your bracket. Use the editable PDF to make your predictions. Save your changes!
- Email your bracket to JBC. Double-check your entry, and then email it to methods@asbmb.org.
- Follow JBC on Twitter and vote for your favorite methods. The JBC Twitter handle is @JBiolChem. They'll be posting weekly polls. Don't forget to participate.
Visit the JBC Methods Madness website for the complete rules.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.
Latest in Science
Science highlights or most popular articles
Brain Injury Awareness Month 2021
In the U.S., about 2.8 million people sustain a traumatic brain injury annually. Learn about recent research on TBI-related dementia, dysfunctional mitochondria and other work powering the march toward better therapies.
The evolution of proteins from mysteries to medicines
An essay in observance of National Protein Day.
'Every experiment and every breakthrough matters'
An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.
Progeria: From the unknown to the first FDA-approved treatment
Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.
Raising awareness and funding for Pompe disease
Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.
A novel approach to septic shock leads to a prospective new therapy
A French research team finds new evidence supporting endotoxin removal for treating life-threatening inflammation.